July 30 (Reuters) – Recce Pharmaceuticals Ltd: * U.S. GOVERNMENT RELEASES US$66.9B AMR BIODEFENSE STRATEGY * DEVELOPING NEW CLASS OF SYNTHETIC ANTI- INFECTIVES DESIGNED TO ADDRESS ANTIBIOTIC-RESISTANT
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)